加拿大消化健康基金会公共影响系列。加拿大的炎症性肠病：发病率、患病率以及直接和间接经济影响。
Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact.
作者信息
Fedorak Richard N, Wong Karen, Bridges Ron
机构信息
Division of Gastroenterology, University of Alberta, Edmonton, Alberta.
出版信息
Can J Gastroenterol. 2010 Nov;24(11):651-5. doi: 10.1155/2010/407095.
Abstract
The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada in 2009. The current article presents the updated findings from the study concerning inflammatory bowel diseases - specifically, Crohn's disease and ulcerative colitis.
摘要
加拿大消化健康基金会于2009年启动了一项科学计划，以评估加拿大消化系统疾病的发病率、患病率、死亡率及经济影响。本文介绍了该研究关于炎症性肠病（特别是克罗恩病和溃疡性结肠炎）的最新研究结果。
相似文献
1
Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact.加拿大消化健康基金会公共影响系列。加拿大的炎症性肠病：发病率、患病率以及直接和间接经济影响。
Can J Gastroenterol. 2010 Nov;24(11):651-5. doi: 10.1155/2010/407095.
2
Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact.加拿大消化健康基金会公共影响系列3：加拿大的肠易激综合征。发病率、患病率以及直接和间接经济影响。
Can J Gastroenterol. 2012 May;26(5):252-6. doi: 10.1155/2012/861478.
3
Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact.加拿大消化健康基金会公共影响系列：加拿大的胃食管反流病：发病率、患病率以及直接和间接经济影响。
Can J Gastroenterol. 2010 Jul;24(7):431-4. doi: 10.1155/2010/296584.
4
Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey.加拿大炎症性肠病导致的工作损失：一项全国人口健康调查的结果
Am J Gastroenterol. 2003 Apr;98(4):844-9. doi: 10.1111/j.1572-0241.2003.07378.x.
5
Canadian Digestive Health Foundation Public Impact Series 4: celiac disease in Canada. Incidence, prevalence, and direct and indirect economic impact.加拿大消化健康基金会公共影响系列4：加拿大的乳糜泻。发病率、患病率以及直接和间接经济影响。
Can J Gastroenterol. 2012 Jun;26(6):350-2. doi: 10.1155/2012/384787.
6
Canadian Digestive Health Foundation Public Impact Series 5: Pancreatitis in Canada. Incidence, prevalence, and direct and indirect economic impact.加拿大消化健康基金会公共影响系列5：加拿大的胰腺炎。发病率、患病率以及直接和间接经济影响。
Can J Gastroenterol. 2012 Aug;26(8):544-5. doi: 10.1155/2012/795149.
7
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率：基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
8
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.加拿大一所三级护理大学医院中炎症性肠病患者的直接住院费用。
Am J Gastroenterol. 2000 Mar;95(3):677-83. doi: 10.1111/j.1572-0241.2000.01845.x.
9
Crohn's disease and ulcerative colitis: morbidity and mortality.克罗恩病和溃疡性结肠炎：发病率与死亡率
Health Rep. 1990;2(4):343-59.
10
Inflammatory bowel disease: medical cost algorithms.炎症性肠病：医疗费用算法
J Clin Gastroenterol. 1992 Jun;14(4):318-27. doi: 10.1097/00004836-199206000-00010.
引用本文的文献
1
Primary healthcare provider-perceived barriers to implementing an evidence-based pathway for undifferentiated lower gastrointestinal tract symptoms: A qualitative inquiry.初级医疗服务提供者认为在实施针对未分化下消化道症状的循证路径时存在的障碍：一项定性研究。
PLoS One. 2024 Dec 31;19(12):e0313201. doi: 10.1371/journal.pone.0313201. eCollection 2024.
2
Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.炎症性肠病和结直肠癌的新型生物标志物：代谢失调与过度炎症的相互作用。
Int J Mol Sci. 2023 Mar 22;24(6):5967. doi: 10.3390/ijms24065967.
3
Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease.炎症性肠病患者血清素信号传导成分的特征分析
J Can Assoc Gastroenterol. 2019 Aug;2(3):132-140. doi: 10.1093/jcag/gwy039. Epub 2018 Aug 10.
4
Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures.炎症性肠病患者对诊断及监测检查和程序的认知
BMC Gastroenterol. 2019 Feb 13;19(1):30. doi: 10.1186/s12876-019-0946-8.
5
The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.炎症性肠病患儿的就诊频率与药物依从性或结局无关。
Can J Gastroenterol Hepatol. 2018 Feb 25;2018:4687041. doi: 10.1155/2018/4687041. eCollection 2018.
6
Suppression of methionine-induced colon injury of young rats by cysteine and N-acetyl-L-cysteine.半胱氨酸和 N-乙酰-L-半胱氨酸对蛋氨酸诱导的幼鼠结肠损伤的抑制作用。
Mol Cell Biochem. 2018 Mar;440(1-2):53-64. doi: 10.1007/s11010-017-3155-1. Epub 2017 Aug 17.
7
Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis.现实治疗模式表明阿达木单抗治疗溃疡性结肠炎具有成本效益。
Can J Gastroenterol Hepatol. 2016;2016:5315798. doi: 10.1155/2016/5315798. Epub 2016 Oct 3.
8
Etrolizumab for induction of remission in ulcerative colitis.艾托珠单抗用于诱导溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2015 Dec 2;2015(12):CD011661. doi: 10.1002/14651858.CD011661.pub2.
9
Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.高同型半胱氨酸血症作为炎症性肠病中结直肠癌发生的潜在促成因素：综述
World J Gastroenterol. 2015 Jan 28;21(4):1081-90. doi: 10.3748/wjg.v21.i4.1081.
10
5-HT7 receptor signaling: improved therapeutic strategy in gut disorders.5-羟色胺7受体信号传导：肠道疾病治疗策略的改进
Front Behav Neurosci. 2014 Dec 11;8:396. doi: 10.3389/fnbeh.2014.00396. eCollection 2014.
本文引用的文献
1
Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006.1996 年至 2006 年加利福尼亚北部儿童炎症性肠病的发病率、流行率和时间趋势。
J Pediatr. 2010 Aug;157(2):233-239.e1. doi: 10.1016/j.jpeds.2010.02.024. Epub 2010 Apr 18.
2
Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies.基于人群的研究的克罗恩病总体和病因特异性死亡率的荟萃分析。
Inflamm Bowel Dis. 2010 Feb;16(2):347-53. doi: 10.1002/ibd.21007.
3
Epidemiology of Crohn's disease in Québec, Canada.加拿大魁北克省克罗恩病的流行病学
Inflamm Bowel Dis. 2009 Mar;15(3):429-35. doi: 10.1002/ibd.20756.
4
New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations.克罗恩病的新全球地图：基因、环境及社会经济相关性
Inflamm Bowel Dis. 2008 May;14(5):709-20. doi: 10.1002/ibd.20352.
5
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States.美国克罗恩病和溃疡性结肠炎的患病率及地理分布。
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1424-9. doi: 10.1016/j.cgh.2007.07.012. Epub 2007 Sep 29.
6
Meta-analysis: mortality in Crohn's disease.荟萃分析：克罗恩病的死亡率
Aliment Pharmacol Ther. 2007 Apr 15;25(8):861-70. doi: 10.1111/j.1365-2036.2007.03276.x.
7
Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies.溃疡性结肠炎的总体死亡率和特定病因死亡率：基于人群的起始队列研究的荟萃分析。
Am J Gastroenterol. 2007 Mar;102(3):609-17. doi: 10.1111/j.1572-0241.2006.01000.x.
8
The epidemiology of inflammatory bowel disease in Canada: a population-based study.加拿大炎症性肠病的流行病学：一项基于人群的研究。
Am J Gastroenterol. 2006 Jul;101(7):1559-68. doi: 10.1111/j.1572-0241.2006.00603.x.
9
Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey.炎症性肠病患者使用或不使用补充和替代医学的原因：一项加拿大全国性调查。
Can J Gastroenterol. 2005 Sep;19(9):567-73. doi: 10.1155/2005/943547.
Zotero 插件